Study protocol for a group-based motivational interviewing brief intervention to reduce substance use and sexual risk behavior among young adults experiencing homelessness.


Journal

Addiction science & clinical practice
ISSN: 1940-0640
Titre abrégé: Addict Sci Clin Pract
Pays: England
ID NLM: 101316917

Informations de publication

Date de publication:
28 07 2020
Historique:
received: 12 03 2020
accepted: 17 07 2020
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 2 9 2021
Statut: epublish

Résumé

Young people experiencing homelessness have alarmingly high rates of alcohol and other drug (AOD) use, which is associated with sexual risk behaviors such as unprotected sex, trading sex, and sex with multiple casual partners. Few risk reduction programs for this population have been developed and rigorously evaluated, particularly those that address both of these interrelated behaviors, use a collaborative and non-judgmental approach, and are feasible to deliver in settings where homeless young people seek services. This paper describes the protocol of a study evaluating a four-session Motivational Interviewing (MI)-based group risk reduction intervention for this population. The protocol has been shown to be efficacious in pilot work over 3 months with 200 homeless young adults [1]. The current study seeks to refine the intervention protocol and evaluate the program on a larger scale. In a cluster-cross-over randomized controlled trial, 18-25 year olds will receive the AWARE risk reduction program (n = 200) or standard care (n = 200) at one of three drop-in centers serving homeless youth in the Los Angeles area. We will evaluate intervention effects on primary outcomes of AOD use and sexual risk behavior, as well as secondary outcomes of health-related quality of life and social stability, over a 12-month period. This project has the potential to fill a significant gap in prevention services by demonstrating that a brief intervention, feasible to deliver within settings where young people experiencing homelessness typically seeks services, can significantly reduce the interrelated problems of AOD use and sexual risk behavior. Trial registration ClinicalTrials.gov Identifier: NCT03735784. Registered November 18, 2018, https://clinicaltrials.gov/ct2/show/record/NCT03735784 (retrospectively registered).

Sections du résumé

BACKGROUND
Young people experiencing homelessness have alarmingly high rates of alcohol and other drug (AOD) use, which is associated with sexual risk behaviors such as unprotected sex, trading sex, and sex with multiple casual partners. Few risk reduction programs for this population have been developed and rigorously evaluated, particularly those that address both of these interrelated behaviors, use a collaborative and non-judgmental approach, and are feasible to deliver in settings where homeless young people seek services. This paper describes the protocol of a study evaluating a four-session Motivational Interviewing (MI)-based group risk reduction intervention for this population. The protocol has been shown to be efficacious in pilot work over 3 months with 200 homeless young adults [1]. The current study seeks to refine the intervention protocol and evaluate the program on a larger scale.
METHODS/DESIGN
In a cluster-cross-over randomized controlled trial, 18-25 year olds will receive the AWARE risk reduction program (n = 200) or standard care (n = 200) at one of three drop-in centers serving homeless youth in the Los Angeles area. We will evaluate intervention effects on primary outcomes of AOD use and sexual risk behavior, as well as secondary outcomes of health-related quality of life and social stability, over a 12-month period.
DISCUSSION
This project has the potential to fill a significant gap in prevention services by demonstrating that a brief intervention, feasible to deliver within settings where young people experiencing homelessness typically seeks services, can significantly reduce the interrelated problems of AOD use and sexual risk behavior. Trial registration ClinicalTrials.gov Identifier: NCT03735784. Registered November 18, 2018, https://clinicaltrials.gov/ct2/show/record/NCT03735784 (retrospectively registered).

Identifiants

pubmed: 32723349
doi: 10.1186/s13722-020-00201-x
pii: 10.1186/s13722-020-00201-x
pmc: PMC7390162
doi:

Banques de données

ClinicalTrials.gov
['NCT03735784']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

26

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA025641
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01AA025641
Pays : United States

Références

Perspect Sex Reprod Health. 2012 Dec;44(4):252-61
pubmed: 23231333
Int J STD AIDS. 1997 Feb;8(2):109-17
pubmed: 9061410
Subst Abus. 2010 Jan;31(1):24-34
pubmed: 20391267
Child Youth Serv Rev. 2009 Jul;31(7):732-742
pubmed: 20161294
AIDS Behav. 2009 Feb;13(1):154-64
pubmed: 18535902
J Child Sex Abus. 2016 Jul;25(5):524-37
pubmed: 27266400
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Perspect Sex Reprod Health. 2015 Dec;47(4):195-201
pubmed: 26575948
Health Serv Res. 2018 Dec;53(6):4609-4628
pubmed: 29862501
J Adolesc Health. 2016 Aug;59(2):144-53
pubmed: 27238839
Drug Alcohol Depend. 2010 Nov 1;112(1-2):140-9
pubmed: 20656423
J Occup Health Psychol. 2005 Oct;10(4):363-381
pubmed: 16248686
J Couns Psychol. 2015 Jan;62(1):79-86
pubmed: 25602608
Addiction. 2007 Aug;102(8):1234-43
pubmed: 17565560
J Subst Abuse Treat. 2008 Jul;35(1):53-61
pubmed: 18037603
Psychol Addict Behav. 2018 Dec;32(8):873-884
pubmed: 30556713
Sex Health. 2007 Mar;4(1):57-61
pubmed: 17382040
Child Youth Serv Rev. 2014 Aug 1;43:118-123
pubmed: 25104870
Health Serv Res. 2000 Feb;34(6):1273-302
pubmed: 10654830
Psychol Addict Behav. 2017 Sep;31(6):688-698
pubmed: 28627914
Health Psychol. 2013 Oct;32(10):1093-103
pubmed: 23772887
AIDS Behav. 2017 Mar;21(3):688-702
pubmed: 27885551
J Adolesc. 2009 Apr;32(2):357-77
pubmed: 18760466
J Ethn Subst Abuse. 2008;7(1):23-40
pubmed: 19842299
JAMA. 1991 Sep 4;266(9):1237-41
pubmed: 1870249
Prev Sci. 2007 Mar;8(1):35-49
pubmed: 17096196
AIDS Care. 2017 Apr;29(4):481-488
pubmed: 27539676
Am J Drug Alcohol Abuse. 2018;44(5):551-560
pubmed: 29286835
AIDS Behav. 2008 May;12(3):374-83
pubmed: 18330687
Child Maltreat. 2015 May;20(2):115-24
pubmed: 25510502
J Am Coll Health. 1998 Nov;47(3):113-21
pubmed: 9830817
Psychol Addict Behav. 2011 Dec;25(4):583-94
pubmed: 21928866
J Drug Issues. 2005 Fall;35(4):799-816
pubmed: 21533015
J Prev Interv Community. 2009;37(2):112-28
pubmed: 19363772
J Subst Abuse Treat. 2020 Apr;111:86-99
pubmed: 32087841
Addict Sci Clin Pract. 2012 Jun 08;7:8
pubmed: 23186265
J Adolesc. 2014 Jul;37(5):531-42
pubmed: 24931556
AIDS Behav. 2018 Nov;22(11):3508-3518
pubmed: 29725788
J Drug Educ. 1995;25(3):191-209
pubmed: 7500223
J Subst Abuse Treat. 2013 Nov-Dec;45(5):400-8
pubmed: 23891459
Field methods. 2018 Feb 1;30(1):22-36
pubmed: 30555283
Psychol Addict Behav. 2012 Dec;26(4):994-1000
pubmed: 22642853
J Res Adolesc. 2012 Sep 1;22(3):571-582
pubmed: 23264722
J Behav Health Serv Res. 2019 Apr;46(2):234-248
pubmed: 30291586
J Prim Prev. 2018 Jun;39(3):247-262
pubmed: 29754166
J Subst Abuse Treat. 2017 May;76:20-27
pubmed: 28340904
J Consult Clin Psychol. 2015 Feb;83(1):68-80
pubmed: 25365779
J Behav Med. 2016 Jun;39(3):371-85
pubmed: 26831053
Drug Alcohol Depend. 2019 Jul 1;200:153-160
pubmed: 31132682
Psychol Addict Behav. 2015 Dec;29(4):941-9
pubmed: 26415055
Womens Health Issues. 2009 May-Jun;19(3):193-201
pubmed: 19345588
AIDS Educ Prev. 2001 Apr;13(2):131-48
pubmed: 11398958
Health Technol Assess. 2007 Oct;11(43):iii, ix-107
pubmed: 17935683
Am J Addict. 2006;15 Suppl 1:80-91
pubmed: 17182423
Child Abuse Negl. 1999 Dec;23(12):1295-306
pubmed: 10626612
Addict Behav. 2005 Oct;30(9):1797-810
pubmed: 16111834
J Consult Clin Psychol. 2006 Feb;74(1):160-7
pubmed: 16551153
Cochrane Database Syst Rev. 2011 Jan 19;(1):CD007501
pubmed: 21249691
J Stud Alcohol. 2003 Jan;64(1):5-14
pubmed: 12608478
PLoS One. 2015 Oct 08;10(10):e0139518
pubmed: 26447792
Multivariate Behav Res. 2008 Apr 2;43(2):210-236
pubmed: 20396621
Psychol Addict Behav. 2007 Dec;21(4):582-6
pubmed: 18072842
New Dir Youth Dev. 2014 Spring;2014(141):57-65, 11
pubmed: 24753278
Am J Addict. 2008 May-Jun;17(3):224-34
pubmed: 18464000
Child Sch. 2005 Jul 1;27(3):133-145
pubmed: 21359122
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
J Adolesc Health. 2013 Oct;53(4):486-91
pubmed: 23871131
Ann Appl Stat. 2011 Jun;5(2A):605-627
pubmed: 21857889
Prev Sci. 2018 May;19(4):459-467
pubmed: 29352399
Prev Sci. 2003 Sep;4(3):173-87
pubmed: 12940468
AIDS Behav. 2012 Aug;16(6):1699-707
pubmed: 21932093
Psychol Addict Behav. 2006 Sep;20(3):254-64
pubmed: 16938063
AIDS Behav. 2011 Feb;15(2):253-60
pubmed: 20848305
AIDS Behav. 2017 Sep;21(9):2717-2725
pubmed: 28409267
Prev Sci. 2012 Aug;13(4):415-25
pubmed: 22311178
Alcohol Treat Q. 2010 Oct;28(4):417-436
pubmed: 21113392

Auteurs

Joan S Tucker (JS)

RAND Corporation, 1776 Main Street, PO Box 2136, Santa Monica, CA, 90407-2138, United States. jtucker@rand.org.

Elizabeth J D'Amico (EJ)

RAND Corporation, 1776 Main Street, PO Box 2136, Santa Monica, CA, 90407-2138, United States.

Eric R Pedersen (ER)

RAND Corporation, 1776 Main Street, PO Box 2136, Santa Monica, CA, 90407-2138, United States.
Department of Psychiatry and Behavioral Sciences, Keck School of Medicine, University of Southern California, 250 Alcazar Street, Suite 2200, Los Angeles, CA, 90033, United States.

Anthony Rodriguez (A)

RAND Corporation, 20 Park Plaza, Suite 920, Boston, MA, 02116, United States.

Rick Garvey (R)

RAND Corporation, 1776 Main Street, PO Box 2136, Santa Monica, CA, 90407-2138, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH